NEW YORK / Aug 05, 2024 / Business Wire / As required by the rules of the New York Stock Exchange, MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”) today announced that it has granted to Douglas Garis, the Company’s recently appointed Executive Vice President, Chief Financial Officer and Treasurer, on August 5, 2024, employment inducement awards consisting of the following: (i) 4,901,960 stock options with such options vesting over a three-year period from August 5, 2024, in substantially equal annual installments, subject to Mr. Garis’ continued employment; and (ii) 3,571,428 restricted stock units with such units vesting over a three-year period from August 5, 2025, in substantially equal annual installments, subject to Mr. Garis’ continued employment. These awards were granted to Mr. Garis pursuant to the terms of his employment agreement.
MultiPlan also announced that it has granted to William Mintz, the Company’s recently appointed Senior Vice President, Corporate Affairs and Strategy, on August 5, 2024, employment inducement awards consisting of 1,928,571 restricted stock units with such units vesting over a four-year period from August 5, 2024, in substantially equal annual installments, subject to Mr. Mintz’s continued employment. These awards were granted to Mr. Mintz pursuant to the terms of his offer letter.
These awards were granted outside the Plan, but except as set forth in the award agreements, will generally be subject to the same terms and conditions as apply to the applicable awards granted under the Company’s 2020 Omnibus Incentive Plan, as amended. The Compensation Committee of MultiPlan’s Board of Directors approved these employment inducement awards in reliance on the employment inducement exception to shareholder approval provided under Section 303A.08 of the NYSE Listed Company Manual. To comply with the terms of this exemption, these employment inducement awards require public announcement of the awards and written notice to the NYSE.
About MultiPlan
MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of- pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.
Last Trade: | US$29.20 |
Daily Volume: | 0 |
Market Cap: | US$472.160M |
May 22, 2025 May 08, 2025 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load